KuDOS Pharmaceuticals' Series C Round

KuDOS Pharmaceuticals raised a round of funding on September 02, 2002.

KuDOS is involved in the discovery and development of small molecule drugs based upon the science of DNA damage sensing, signalling and repair to address unmet medical needs in cancer treatment.…

Articles about KuDOS Pharmaceuticals' Series C Round: